These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8473419)

  • 21. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mifepristone: a potential contraceptive.
    Heikinheimo O; Archer DF
    Clin Obstet Gynecol; 1996 Jun; 39(2):461-8. PubMed ID: 8734010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of mifepristone on inhibition of ovulation and induction of luteolysis.
    Spitz IM; Croxatto HB; Lähteenmäki P; Heikinheimo O; Bardin CW
    Hum Reprod; 1994 Jun; 9 Suppl 1():69-76. PubMed ID: 7962472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response to intermittent RU486 in women.
    Spitz IM; Croxatto HB; Salvatierra AM; Heikinheimo O
    Fertil Steril; 1993 May; 59(5):971-5. PubMed ID: 8486197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of low daily doses of mifepristone on ovarian function and endometrial development.
    Danielsson KG; Swahn ML; Westlund P; Johannisson E; Seppälä M; Bygdeman M
    Hum Reprod; 1997 Jan; 12(1):124-31. PubMed ID: 9043916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of tamoxifen alone and in combination with RU 486 on the endometrium in the mid-luteal phase.
    Swahn ML; Bygdeman M; Seppälä M; Johannisson E; Cekan S
    Hum Reprod; 1993 Feb; 8(2):193-200. PubMed ID: 8473418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
    Roseff SJ; Kettel LM; Rivier J; Burger HG; Baulieu E; Yen SS
    Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of once weekly administration of mifepristone on ovarian function in normal women.
    Chen X; Xiao B
    Contraception; 1997 Sep; 56(3):175-80. PubMed ID: 9347209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of levonorgestrel administered in large doses at different stages of the cycle on ovarian function and endometrial morphology.
    Landgren BM; Johannisson E; Aedo AR; Kumar A; Shi YE
    Contraception; 1989 Mar; 39(3):275-89. PubMed ID: 2496951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contraceptive efficacy of low doses of mifepristone.
    Marions L; Danielsson KG; Swahn ML; Bygdeman M
    Fertil Steril; 1998 Nov; 70(5):813-6. PubMed ID: 9806558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of short-term cyclic administration of cyproterone acetate on pituitary-ovarian function in the human.
    Kumari GI; Das RP; Madoiya KK; Jain AK; Roy S
    Fertil Steril; 1977 Nov; 28(11):1168-74. PubMed ID: 562781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
    Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE
    J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of low weekly doses of mifepristone on ovarian function and endometrial development.
    Gemzell-Danielsson K; Westlund P; Johannisson E; Swahn ML; Bygdeman M; Seppälä M
    Hum Reprod; 1996 Feb; 11(2):256-64. PubMed ID: 8671205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Follicle stimulating hormone-granulosa cell axis involvement in the antifolliculotrophic effect of low dose mifepristone (RU486).
    Croxatto HB; Salvatierra AM; Fuentealba B; Leiva L
    Hum Reprod; 1995 Aug; 10(8):1987-91. PubMed ID: 8567827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fertility impairment after mifepristone treatment to rats at proestrus. Actions on the hypothalamic-hypophyseal-ovarian axis.
    Telleria CM; Mezzadri MR; Deis RP
    Contraception; 1997 Oct; 56(4):267-74. PubMed ID: 9408709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
    Lemay A; Faure N
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclic progestin administration brings about luteinization during continuous antiprogestin treatment.
    Kekkonen R; Lähteenmäki P
    Contraception; 1996 Apr; 53(4):193-5. PubMed ID: 8706435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiprogestogens: from abortion to contraception.
    Prog Hum Reprod Res; 1992; (22):6-7. PubMed ID: 12286013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.